Literature DB >> 30407507

Complex sex-biased antibody responses: estrogen receptors bind estrogen response elements centered within immunoglobulin heavy chain gene enhancers.

Bart G Jones1, Robert E Sealy1, Rhiannon R Penkert1, Sherri L Surman1, Robert W Maul2, Geoff Neale3, Beisi Xu4, Patricia J Gearhart2, Julia L Hurwitz1,5.   

Abstract

Nuclear hormone receptors including the estrogen receptor (ERα) and the retinoic acid receptor regulate a plethora of biological functions including reproduction, circulation and immunity. To understand how estrogen and other nuclear hormones influence antibody production, we characterized total serum antibody isotypes in female and male mice of C57BL/6J, BALB/cJ and C3H/HeJ mouse strains. Antibody levels were higher in females compared to males in all strains and there was a female preference for IgG2b production. Sex-biased patterns were influenced by vitamin levels, and by antigen specificity toward influenza virus or pneumococcus antigens. To help explain sex biases, we examined the direct effects of estrogen on immunoglobulin heavy chain sterile transcript production among purified, lipopolysaccharide-stimulated B cells. Supplemental estrogen in B-cell cultures significantly increased immunoglobulin heavy chain sterile transcripts. Chromatin immunoprecipitation analyses of activated B cells identified significant ERα binding to estrogen response elements (EREs) centered within enhancer elements of the immunoglobulin heavy chain locus, including the Eµ enhancer and hypersensitive site 1,2 (HS1,2) in the 3' regulatory region. The ERE in HS1,2 was conserved across animal species, and in humans marked a site of polymorphism associated with the estrogen-augmented autoimmune disease, lupus. Taken together, the results highlight: (i) the important targets of ERα in regulatory regions of the immunoglobulin heavy chain locus that influence antibody production, and (ii) the complexity of mechanisms by which estrogen instructs sex-biased antibody production profiles. © The Japanese Society for Immunology. 2018. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  female; ligand; male; nuclear hormone receptor; vaccine

Mesh:

Substances:

Year:  2019        PMID: 30407507      PMCID: PMC6400052          DOI: 10.1093/intimm/dxy074

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   5.071


  122 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  The thyroid hormones and their nuclear receptors in the gut: from developmental biology to cancer.

Authors:  Maria Sirakov; Michelina Plateroti
Journal:  Biochim Biophys Acta       Date:  2010-12-29

3.  Characterization of estrogen-induced autoantibodies to cardiolipin in non-autoimmune mice.

Authors:  D Verthelyi; S Ansar Ahmed
Journal:  J Autoimmun       Date:  1997-04       Impact factor: 7.094

4.  Dynamic changes in binding of immunoglobulin heavy chain 3' regulatory region to protein factors during class switching.

Authors:  Sanjukta Chatterjee; Zhongliang Ju; Rabih Hassan; Sabrina A Volpi; Alexander V Emelyanov; Barbara K Birshtein
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

Review 5.  The role of nuclear hormone receptors in cutaneous wound repair.

Authors:  Sandra Rieger; Hengguang Zhao; Paige Martin; Koichiro Abe; Thomas S Lisse
Journal:  Cell Biochem Funct       Date:  2014-12-22       Impact factor: 3.685

Review 6.  IgH chain class switch recombination: mechanism and regulation.

Authors:  Janet Stavnezer; Carol E Schrader
Journal:  J Immunol       Date:  2014-12-01       Impact factor: 5.422

7.  Vitamin Supplementation at the Time of Immunization with a Cold-Adapted Influenza Virus Vaccine Corrects Poor Mucosal Antibody Responses in Mice Deficient for Vitamins A and D.

Authors:  S L Surman; R R Penkert; B G Jones; R E Sealy; J L Hurwitz
Journal:  Clin Vaccine Immunol       Date:  2016-01-06

8.  A multi-valent vaccine approach that elicits broad immunity within an influenza subtype.

Authors:  Victor C Huber; Paul G Thomas; Jonathan A McCullers
Journal:  Vaccine       Date:  2009-01-07       Impact factor: 3.641

9.  Multiple parameters control the selectivity of nuclear receptors for their response elements. Selectivity and promiscuity in response element recognition by retinoic acid receptors and retinoid X receptors.

Authors:  S Mader; P Leroy; J Y Chen; P Chambon
Journal:  J Biol Chem       Date:  1993-01-05       Impact factor: 5.157

10.  Increased frequency of the immunoglobulin enhancer HS1,2 allele 2 in coeliac disease.

Authors:  D Frezza; V Giambra; R Cianci; A Fruscalzo; M Giufrè; G Cammarota; C Martìnez-Labarga; O Rickards; G Scibilia; C Sferlazzas; F Bartolozzi; S Starnino; G Magazzù; G B Gasbarrini; F Pandolfi
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423

View more
  17 in total

1.  From Influenza Virus Infections to Lupus: Synchronous Estrogen Receptor α and RNA Polymerase II Binding Within the Immunoglobulin Heavy Chain Locus.

Authors:  Bart G Jones; Robert E Sealy; Rhiannon R Penkert; Sherri L Surman; Barbara K Birshtein; Beisi Xu; Geoffrey Neale; Robert W Maul; Patricia J Gearhart; Julia L Hurwitz
Journal:  Viral Immunol       Date:  2020-02-27       Impact factor: 2.257

2.  Germ-line genetic variation in the immunoglobulin heavy chain creates stroke susceptibility in the spontaneously hypertensive rat.

Authors:  Isha S Dhande; Sterling C Kneedler; Aniket S Joshi; Yaming Zhu; M John Hicks; Scott E Wenderfer; Michael C Braun; Peter A Doris
Journal:  Physiol Genomics       Date:  2019-10-14       Impact factor: 3.107

Review 3.  The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.

Authors:  Alessandro Maglione; Simona Rolla; Stefania Federica De Mercanti; Santina Cutrupi; Marinella Clerico
Journal:  Cells       Date:  2019-10-19       Impact factor: 6.600

4.  Baseline Serum Vitamin A and D Levels Determine Benefit of Oral Vitamin A&D Supplements to Humoral Immune Responses Following Pediatric Influenza Vaccination.

Authors:  Nehali Patel; Rhiannon R Penkert; Bart G Jones; Robert E Sealy; Sherri L Surman; Yilun Sun; Li Tang; Jennifer DeBeauchamp; Ashley Webb; Julie Richardson; Ryan Heine; Ronald H Dallas; A Catharine Ross; Richard Webby; Julia L Hurwitz
Journal:  Viruses       Date:  2019-09-30       Impact factor: 5.048

5.  Effect of Vitamin A Deficiency in Dysregulating Immune Responses to Influenza Virus and Increasing Mortality Rates After Bacterial Coinfections.

Authors:  Rhiannon R Penkert; Amanda P Smith; Eike R Hrincius; Jonathan A McCullers; Peter Vogel; Amber M Smith; Julia L Hurwitz
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

Review 6.  Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses.

Authors:  Charles J Russell; Julia L Hurwitz
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

7.  Influences of Vitamin A on Vaccine Immunogenicity and Efficacy.

Authors:  Rhiannon R Penkert; Hannah M Rowe; Sherri L Surman; Robert E Sealy; Jason Rosch; Julia L Hurwitz
Journal:  Front Immunol       Date:  2019-07-17       Impact factor: 7.561

8.  Autoantibody Responses to Apolipoprotein A-I Are Not Diet- or Sex-Linked in C57BL/6 Mice.

Authors:  Michelle G Pitts; David Nardo; Cierra M Isom; Vincent J Venditto
Journal:  Immunohorizons       Date:  2020-08-05

9.  Consequences of Vitamin A Deficiency: Immunoglobulin Dysregulation, Squamous Cell Metaplasia, Infectious Disease, and Death.

Authors:  Sherri L Surman; Rhiannon R Penkert; Robert E Sealy; Bart G Jones; Tony N Marion; Peter Vogel; Julia L Hurwitz
Journal:  Int J Mol Sci       Date:  2020-08-04       Impact factor: 5.923

Review 10.  Immunoglobulin germline gene variation and its impact on human disease.

Authors:  Ivana Mikocziova; Victor Greiff; Ludvig M Sollid
Journal:  Genes Immun       Date:  2021-06-26       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.